Roche’s first-quarter 2022 sales rose 10 percent on strong U.S. demand for rapid COVID-19 antigen tests and specialty drugs but the Swiss drugmaker reaffirmed that a drop in pandemic-related demand would put the brakes on growth.

The U.S.Food and Drug Administration granted Emergency Use Authorization (EUA) for a breathalyzer that can detect COVID-19 within three minutes.

COVID-19 vaccines using mRNA technology do not affect fertility outcomes during in-vitro fertilization (IVF), researchers found. Other new findings suggest the bacteria living in the small intestine may contribute to the risk for long COVID after infection with SARS-CoV-2.

Abbott Laboratories beat fourth-quarter 2021 profit and sales estimates, aided by robust sales of COVID-19 test kits and strong demand for the company’s diagnostics products, but forecast lower-than-expected COVID-19 testing sales in 2022 due to uncertainties around the future of the pandemic.

The U.S. Defense Department said it awarded on January 7 a contract to Revival Health Inc. for 13.3 million COVID-19 at-home test kits as part of President Joe Biden’s plan to make available 500 million test kits.

Walmart Inc. said the company would run a pilot project to deliver self-collection test kits for coronavirus through automated drones at customers’ doorsteps.

Silicon Valley medical equipment startup Visby Medical received Emergency Use Authorization by the U.S. Food and Drug Administration for a portable PCR Covid-19 test kit, the first company to do so, according to the FDA.

Shares of Abbott Laboratories dipped in trading following reports of a new study showing that the company’s approved COVID-19 testing kits have fallen short in accurately detecting the novel coronavirus.

The U.S. Food and Drug Administration said the regulatory agency would require antibody tests for the new coronavirus to undergo an agency review, reversing an earlier policy that had allowed fraudulent products to be marketed.

World leaders pledged to accelerate work on tests, drugs and vaccines against COVID-19 and to share them around the globe, but the United States did not take part in the launch of the World Health Organization (WHO) initiative.